本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

146.23
-5.6000-3.69%
盤後146.230.00000.00%16:28 EDT
成交量:281.41萬
成交額:4.14億
市值:149.15億
市盈率:21.43
高:152.63
開:152.63
低:146.06
收:151.83
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:2.70
換手率:2.81%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.04
市盈率(LYR):31.31

資料載入中...

2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/12

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

年度報告

Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/05

重要事件披露

Current report, items 2.02 and 9.01
2020/02/04

重要事件披露

Current report, items 2.02, 5.02, 5.03, and 9.01
2020/01/13

重要事件披露

Current report, items 2.02 and 9.01
2019/12/11

超過5%披露

General statement of acquisition of beneficial ownership
2019/12/10

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/11/19

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/13

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/11/05

員工持股計劃

Securities to be offered to employees in employee benefit plans
2019/11/04

季度報告

Quarterly report [Sections 13 or 15(d)]
2019/11/04

重要事件披露

Current report, items 2.02 and 9.01
2019/10/16

持股變動聲明

Statement of changes in beneficial ownership of securities
2019/10/04

持股變動聲明

Statement of changes in beneficial ownership of securities